CFM
KNSA icon

Cornerstone Financial Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Cornerstone Financial Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.81K Buy
44
+1
+2% +$52 ﹤0.01% 748
2026
Q1 		$2.07K Buy
43
+11
+34% +$487 ﹤0.01% 722
2025
Q4 		$1.32K Buy
+32
New +$1.28K ﹤0.01% 827

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Cornerstone Financial Management's KNSA Position: Q2 2026 in Review

Cornerstone Financial Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 2.3% in Q2 2026, buying an estimated $52 and bringing the position to 44 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #748.

Cornerstone Financial Management first reported a position in KNSA in Q4 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Cornerstone Financial Management held 44 shares of Kiniksa Pharmaceuticals worth $2.81K as of Q2 2026.
  • Cornerstone Financial Management bought 1 Kiniksa Pharmaceuticals share in Q2 2026, an estimated $52.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #748 holding.
  • Cornerstone Financial Management first reported a position in Kiniksa Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.